Michael Lowry
Ceist:474. Deputy Michael Lowry asked the Minister for Health the reasons pembrolizumab is reserved for the first-line treatment of certain cancers; the reason it is not approved for those currently receiving second-line cancer treatment therapy; if he will review the case of a person (details supplied); to initiate discussions with HSE officials to review the criteria for pembrolizumab as a second-line treatment option, emphasising the urgency and potential benefits of pembrolizumab for breast cancer treatment; and if he will make a statement on the matter. [27130/24]
Amharc ar fhreagra